A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis.

Hille, Matthew M; Spangler, Matthew L; Clawson, Michael L; Heath, Kelly D; Vu, Hiep L X; Rogers, Rachel E S; Loy, John Dustin

Hille, Matthew M; Spangler, Matthew L; Clawson, Michael L; Heath, Kelly D; Vu, Hiep L X; Rogers, Rachel E S; Loy, John Dustin.

Afiliación

Hille MM; School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0907, USA.
Spangler ML; Department of Animal Science, University of Nebraska, Lincoln, NE 68583-0908, USA.
Clawson ML; United States Meat Animal Research Center, Clay Center, NE 68933, USA.
Heath KD; School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583-0907, USA.
Vu HLX; Department of Animal Science, University of Nebraska, Lincoln, NE 68583-0908, USA.
Rogers RES; Nebraska Center for Virology, University of Nebraska, Lincoln, NE 68583-0900, USA.
Loy JD; Department of Statistics, University of Nebraska, Lincoln, NE 68583-0963, USA.

Vaccines (Basel) ; 10(6)2022 Jun 09.

Article en En | MEDLINE | ID: mdl-35746524

Palabras clave

Moraxella bovis; Moraxella bovoculi; Mycoplasma bovoculi; bovine pinkeye; infectious bovine keratoconjunctivitis; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google